Pillsbury Winthrop Shaw Pittman LLP advised Alume Biosciences on the deal.Alume Biosciences, a leader in the field of nerve-targeted diagnostics and therapeutics, announced a $13 million Series…
Alume Biosciences’ $13 Million Series B Financing Round
